PROSPECTIVE TRIAL OF OKT3 FOR EARLY PROPHYLAXIS OF REJECTION IN IMMUNOLOGICAL HIGH-RISK RENAL-TRANSPLANT RECIPIENTS - LONG-TERM RESULTS

被引:0
作者
POMER, S
WALDHERR, R
MOHRING, K
KEMPTER, F
WIESEL, M
WEIMER, R
机构
[1] UNIV HEIDELBERG,DEPT TRANSPLANTAT IMMUNOL,W-6900 HEIDELBERG,GERMANY
[2] UNIV HEIDELBERG,DEPT PATHOL,W-6900 HEIDELBERG,GERMANY
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1732 / 1733
页数:2
相关论文
共 5 条
[1]  
GOLDSTEIN G, 1985, NEW ENGL J MED, V313, P337
[2]  
KREIS H, 1985, TRANSPLANT P, V17, P1315
[3]   EARLY USE OF OKT3 MONOCLONAL-ANTIBODY IN RENAL-TRANSPLANTATION TO PREVENT REJECTION [J].
NORMAN, DJ ;
SHIELD, CF ;
BARRY, J ;
BENNETT, WM ;
HENELL, K ;
KIMBALL, J ;
FUNNELL, B ;
HUBERT, B .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1988, 11 (02) :107-110
[4]  
POMER S, 1989, NIEREN HOCHDRUCK, V18, P272
[5]  
TOLEDOPEREYRA LH, 1988, TRANSPLANT P, V20, P910